Biden Administration
Refine Search
Pharmaceutical
Swiss drugmaker Novartis has launched legal action against the US Government, after authorities revealed the first drugs to be subject to pricing regulations ma 7 September 2023
Pharmaceutical
Astellas Pharma withdraws lawsuit challenging USA’s IRA 7 September 2023
Pharmaceutical
CMS reveals first 10 drugs selected for Medicare price negotiation 29 August 2023
Pharmaceutical
The list of companies and groups that are suing the US government over its Medicare price-setting policies continues to grow. 25 August 2023
Biotechnology
In the latest reminder about the lingering presence of COVID-19, the US Department of Health and Human Services (HHS) has awarded more than $1.4 billion for Pro 23 August 2023
Pharmaceutical
The US Supreme Court is to hear a challenge from the Biden administration to the settlement agreed by Purdue Pharma that would protect owners the Sackler family 11 August 2023
Pharmaceutical
US healthcare conglomerate Johnson & Johnson and Japanese drugmaker Astellas have joined a growing list of companies and groups that are suing the US government 20 July 2023
Pharmaceutical
A report commissioned by Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group representing big pharma in the USA, has highlighted the r 10 July 2023
Pharmaceutical
Further HHS moves to protect consumers and lower health care costs 7 July 2023
Pharmaceutical
An Expert View from Chris Blanchette, Novo Nordisk (NOV: N), Kathy Lang, PRECISIONheor, Ross Maclean, Precision Value & Health. 29 June 2023
Pharmaceutical
The US drug industry is not happy with the Inflation Reduction Act (IRA) and is pursuing broad legal action in an attempt to limit its impact. 22 June 2023
Pharmaceutical
The Biden administration has provided more evidence of its desire to follow rhetoric with action on lowering drug prices through the Inflation Reduction Act (IR 12 June 2023
Pharmaceutical
Findings funded by the US biotech industry suggest the Inflation Reduction Act could have a negative impact on drug development. 2 June 2023
Pharmaceutical
A new proposal from the US Department of Health and Human Services (HHS) is proposing steps to further drive down prescription drug costs in Medicaid, building 24 May 2023
Pharmaceutical
A US program worth at least $5 billion is on its way to power development of new COVID-19 vaccines and treatments. 12 April 2023
Pharmaceutical
Texas judge suspends approval of abortion pill mifepristone 11 April 2023
Pharmaceutical
The administrators of the USA’s public insurance scheme, Medicare, are getting ready to implement the measures included in the Inflation Reduction Act. 4 April 2023
Pharmaceutical
Implementation is moving forward on President Joe Biden’s Inflation Reduction Act (IRA) policy that allows Medicare to negotiate lower prescription drug prices. 16 March 2023
Pharmaceutical
The impact of US President Joe Biden's Inflation Reduction Act is beginning to be felt, as Danish diabetes giant Novo Nordisk (NOV: N) announced plans to slash 15 March 2023
Biotechnology
The US Department of Health and Human Services (HHS), through the Centers for Medicare and Medicaid Services (CMS), has announced 27 prescription drugs for whic 15 March 2023
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze